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Enterocutaneous fistulas (ECFs) can be one of the complications found after surgical inter-
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vention for rectal cancer. Interventional modalities consisting of surgical, endoscopic, and
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radiological methods are often implemented to treat postoperative symptomatic compli-
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cations. We present the case of 61-year-old Caucasian man who presented to us with a recent
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diagnosis of rectal cancer that had invaded the levators as well as anteriorly into the pros-
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tate, and who underwent low anterior resection with a diverting loop ileostomy. The patient
was found to have a persistent presacral abscess due to an ECF tract. This case highlights
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Case report
A 61-year-old Caucasian man presented with a recent diagnosis of rectal cancer that had invaded the levators as
well as anteriorly into the prostate. Following neoadjuvant
chemoradiation, the patiens underwent robotic low anterior
resection (LAR) with a diverting loop ileostomy on March 2015.
Fourteen days following surgery, a computed tomography (CT)
scan demonstrated that the patient had a presacral abscess.
To drain the abscess, interventional radiology (IR) percutaneously placed an 8.5-French all-purpose drainage catheter

(Cook Inc, Bloomington, IN) from a right posterior transgluteal
approach. The patient underwent an additional 8 weeks of chemotherapy and the abscess drainage catheter remained in place
during this time. The drainage catheter was removed after
output decreased to a minimal amount (ie, less than 10 cc/
24 h for several days) and a follow-up CT scan that showed a
resolution of the presacral abscess. However, the scan, performed with intravenous (IV) and rectal contrast, documented
the presence of a rectal leak. The patient later underwent small
bowel resection and anastomosis on Oct 30, 2015. Following
the surgical procedure, the patient started having a foulsmelling diarrhea. The patient denied fevers, abdominal pain,
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or rectal bleeding. Stool cultures were negative for both Clostridium difficile and Escherichia coli. The patient’s vital signs
remained stable. The patient experienced fevers and fatigue
and was readmitted to the hospital in November 20, 2015, to
receive IV fluids and antibiotics and to rule out recurrent infections or pelvic fluid collections.
During the hospital admission, the patient received IV fluids
and antibiotics. A CT scan demonstrated a recurrent rimenhancing 7.0 × 4.8 cm fluid collection within the presacral
space extending along the levator ani muscles. IR replaced
the 8.5-French drainage catheter (Cook Inc) through the right
transgluteal tract to drain the purulent fluid in the presacral
space. Two weeks later, a follow-up CT scan of the abdomen
and pelvis showed that the size of the fluid collection had
decreased. An injection of contrast through the tube documented a connection between the presacral abscess and the
rectum consistent with a leak and a fistula. Five months later,
the drain in the right transgluteal tract was removed. Two
months later, the patient presented to the IR service after a
CT scan of the abdomen and pelvis again demonstrated a rimenhancing 5.4 × 2.0 cm perirectal abscess within the presacral
space and extending along the levator ani muscles. From a
left transgluteal approach, IR placed a 10.2-French Cook DawsonMueller drainage catheter (Cook Inc) within the presacral
abscess collection. A sinogram showed a fistula in the upper
rectum and the distal sigmoid that arose from the posteriorlateral wall. The patient was sent home on a 2-week course
of ciprofloxacin and flagyl. Following the 2-week course, the
patient returned to the clinic due to the drain not working
properly (ie, occluded due to debris in the drainage catheter
lumen). The patient’s left transgluteal drainage catheter was
upsized and the patient was started on oral augmentin. The
patient returned to the clinic 14 days later due to continued
drainage from the left drain as well as new drainage from
the previously closed and healed right transgluteal tube tract.
A dark brown material was noted from the skin drainage site.
The patient also reported rectal incontinence. IR was consulted to assist with management of this patient. IR initially
tried closing the old right tube tract with Gelfoam, which failed
within days of the tube tract injection.
The patient returned to IR 7 days later. A Reliant balloon
(Medtronic Reliant, Santa Rosa, CA) (soft and deformable and
normally used for aortic stent grafts) was advanced over a
Bentson guidewire (Cook Inc) through the rectum up to the level
of the leak approximately 8 cm into the rectum. This was gently
inflated with approximately 15 cc of dilute contrast. This large
balloon was used to prevent Onyx 34 from spilling into the
rectum. Through the previous patent transgluteal tube tract
(now an enterocutaneous fistula [ECF]), a hydrophilic coated
angled catheter was advanced over a hydrophilic guidewire and
was used to negotiate and outline the presacral abscess space.
Having outlined the anatomy and the precise location of the
leak, the catheter was slowly withdrawn as 2.4 cc of Onyx 34
was injected into the right transgluteal tract. Through the left
fistula tract, a Kumpe catheter (Cook Inc) was advanced over
a Benton guidewire and Onyx 34 was injected, filling the rectal
leak site, the abscess cavity, and the tube tract. Dimethyl sulfoxide was used to purge the catheters before injecting Onyx
34. Once Onyx 34 was injected, the rectal ballon was deflated
and removed.
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Post-treatment
Six hours following the use of Onyx 34 polymer for embolization of the fistula tracts, the patient reported no drainage
from the previous transgluteal tracts. Follow-up CT scan 3 weeks
later showed a closed left fistula tract but a mild recurrent drainage from the right transgluteal tract. The patient underwent
2 additional Onyx 34 embolizations of the rectal leak site and
a closure of the persistently leaking right transgluteal tract.
At 1 point in the follow-up interval, the patient had a brief
episode of right transgluteal tract drainage. This was treated
with a course of oral augmentin therapy. While on antibiotic
therapy, the tract sealed and rectal discomfort ceased. The
patient is currently asymptomatic at 18 weeks after the last
onyx treatment.

Discussion
ECFs are abnormal sinus tract formations between the alimentary system and the skin surface that can result from
inflammatory bowel disease, abdominal surgery, abscesses, or
iatrogenic causes [1]. The approach to management is focused
on sepsis control, nutritional status, anatomic mapping, and
treatment [1]. The morbidity and mortality rates from ECFs have
been reported to be around 6%-33% [2]. Medical management
is the initial route that is usually undertaken. Nonoperative
closure rates for ECF tracts are around 5%-20% [3]. Even with
low closure rates, medical management acts as a useful adjunct
that allows control of the underlying inflammation, infection, and nutritional imbalances before an operative approach
is undertaken [1]. Surgical closure rates, which involve resection and anastomoses, are anywhere between 75% and 85% [3].
Even with higher closure rates, complications from surgery, such
as a recurrence of the fistula tract, can be debilitating for many
patients. In a large series, the recurrence rate of ECF following operative repair was found to be around 20.5% [4]. Higher
recurrence rates were associated specifically with the surgical oversewing method (36%) vs the resection (16%) of the ECF
[4]. Because recurrences are associated with ECF surgery, alternative and interventional radiological methods in the
community are undertaken in an attempt to adequately manage
ECF without resorting to the operative route.
There have been reports of minimally invasive methods that
have attempted to manage fistula closures. The use of collagen plugs is an alternative method that has been used for the
closure of ECFs. A study by Lyon et al. [5] demonstrated closure
in all fistulas within 2 weeks. The study reported on 6 patients who underwent treatment for an ECF with a Biodesign
ECF plug, which is an extracellular matrix made of collagen
and other materials that aid in tissue repair and closure of the
fistula tract. Only 2 patients (33%) had a recurrence of a fistula
9 and 12 months, respectively [5]. The Biodesign ECF plug
comes in 4- and 7-mm sizes and is delivered through 18- and
22-French sheaths, and is unlikely to work on tracts less than
3 cm [5]. Other noninvasive methods that have been used to
manage fistula tracts are platelet-rich fibrin glue (PRFG) and
vacuum-assisted wound closure.
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Fig. 1 – Anteroposterior (A/P) digital spot image after the
right transgluteal abscess drainage catheter was placed.

PRFG, a fibrin gel containing high concentrations of human
fibrinogen and thrombin, has been used to seal low-output ECF
[6]. The study by Wu et al. examined the use of PRFG in lowoutput ECF, which showed a lesser median time for fistula
closure (7 days) than those who just received supportive care
[6]. Although fibrin glue has been previously used for low-output

Fig. 2 – A/P digital spot image during transgluteal tract
embolization. Note that the large rectal occlusion balloon
has been inflated over the site of leakage. (
). Note the 2
different 5-French catheters ( ) advanced through the
transgluteal tracts.

Fig. 3 – A/P digital spot image after transgluteal tract
occlusion with onyx. Note the water-soluble contrast
outlining the rectum and the remaining colon.

fistula tract closures, PRFG’s lack of transmission of infections, high cost, and allergic reactions make it more versatile
than other fibrin sealants used to seal fistula tracts [6]. Percutaneous embolization of low-output ECF tract with n-butyl-2cyanoacrylate glue and Lipiodol [7]. In the small study performed

Fig. 4 – A/P distal spot image obtained during retreatment.
) and
Note the dense onyx in both transgluteal tracts (
perirectal abscess leak sites ( ). Also, note onyx filling the
anastomotic leak sites. Water-soluble contrast fills the
rectum and the colon.
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abscess cavity and to close bilateral transgluteal tube tracts.
To our knowledge, there have been no previous reported cases
of using ethylene-vinyl alcohol polymer to seal a leak and a
fistula tract causing persistent presacral abscess. Using
Onyx may be an effective method in closing fistula tracts that
develop following LAR in patients who fail conservative management and may defer surgical repair. However, further studies
and long-term follow-up will be needed to determine efficacy (Figs. 1–5).
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